ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Silverback Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – SBTX
November 27, 2021
NEW YORK, Nov. 26, 2021 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Silverback Therapeutics, Inc. (NASDAQ: SBTX): (1) pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s December 3, 2020 initial public offering (“IPO”); and/or (2) between December […]